Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer
- PMID: 9671307
- DOI: 10.1038/28212
Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer
Abstract
Malignant rhabdoid tumours (MRTs) are extremely aggressive cancers of early childhood. They can occur in various locations, mainly the kidney, brain and soft tissues. Cytogenetic and molecular analyses have shown that the deletion of region 11.2 of the long arm of chromosome 22 (22q11.2) is a recurrent genetic characteristic of MRTs, indicating that this locus may encode a tumour suppressor gene. Here we map the most frequently deleted part of chromosome 22q11.2 from a panel of 13 MRT cell lines. We observed six homozygous deletions that delineate the smallest region of overlap between the cell lines. This region is found in the hSNF5/INI1 gene, which encodes a member of the chromatin-remodelling SWI/SNF multiprotein complexes. We analysed the sequence of hSNF5/INI1 and found frameshift or nonsense mutations of this gene in six other cell lines. These truncating mutations of one allele were associated with the loss of the other allele. Identical alterations were observed in corresponding primary tumour DNAs but not in matched constitutional DNAs, indicating that they had been acquired somatically. The observation of bi-allelic alterations of hSNF5/INI1 in MRTs suggests that loss-of-function mutations of hSNF5/INI1 contribute to oncogenesis.
Similar articles
-
Spectrum of hSNF5/INI1 somatic mutations in human cancer and genotype-phenotype correlations.Hum Mol Genet. 1999 Dec;8(13):2359-68. doi: 10.1093/hmg/8.13.2359. Hum Mol Genet. 1999. PMID: 10556283
-
Aberrations of the hSNF5/INI1 gene are restricted to malignant rhabdoid tumors or atypical teratoid/rhabdoid tumors in pediatric solid tumors.Genes Chromosomes Cancer. 2002 May;34(1):33-41. doi: 10.1002/gcc.10052. Genes Chromosomes Cancer. 2002. PMID: 11921280
-
hSNF5/INI1 inactivation is mainly associated with homozygous deletions and mitotic recombinations in rhabdoid tumors.Cancer Res. 1999 Jul 1;59(13):3152-6. Cancer Res. 1999. PMID: 10397258
-
Molecular genetics of atypical teratoid/rhabdoid tumor.Neurosurg Focus. 2006 Jan 15;20(1):E11. doi: 10.3171/foc.2006.20.1.12. Neurosurg Focus. 2006. PMID: 16459991 Review.
-
Integrase interactor 1 in health and disease.Curr Protein Pept Sci. 2015;16(6):478-90. doi: 10.2174/1389203716666150316115156. Curr Protein Pept Sci. 2015. PMID: 25772157 Review.
Cited by
-
Reversible disruption of mSWI/SNF (BAF) complexes by the SS18-SSX oncogenic fusion in synovial sarcoma.Cell. 2013 Mar 28;153(1):71-85. doi: 10.1016/j.cell.2013.02.036. Cell. 2013. PMID: 23540691 Free PMC article.
-
Aurora kinase A, a synthetic lethal target for precision cancer medicine.Exp Mol Med. 2021 May;53(5):835-847. doi: 10.1038/s12276-021-00635-6. Epub 2021 May 28. Exp Mol Med. 2021. PMID: 34050264 Free PMC article. Review.
-
Genetic basis of SMARCB1 protein loss in 22 sinonasal carcinomas.Hum Pathol. 2020 Oct;104:105-116. doi: 10.1016/j.humpath.2020.08.004. Epub 2020 Aug 18. Hum Pathol. 2020. PMID: 32818509 Free PMC article.
-
ARID1A loss is associated with increased NRF2 signaling in human head and neck squamous cell carcinomas.PLoS One. 2024 Feb 15;19(2):e0297741. doi: 10.1371/journal.pone.0297741. eCollection 2024. PLoS One. 2024. PMID: 38358974 Free PMC article.
-
DNA Methylation and Chromatin Remodeling: The Blueprint of Cancer Epigenetics.Scientifica (Cairo). 2016;2016:6072357. doi: 10.1155/2016/6072357. Epub 2016 Mar 28. Scientifica (Cairo). 2016. PMID: 27119045 Free PMC article. Review.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials